Andrew E. Whiteley
Impact in
-
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
-
- Acute Myeloid Leukemia Research
Papers in
-
- Brain Metastases and Treatment 2
-
- Acute Myeloid Leukemia Research 2
- Chronic Myeloid Leukemia Treatments 1
- Co-authors
- Trevor Price (4 shared papers)Dorothy A. Sipkins (4 shared papers)Gaia Cantelli (1 shared paper)David Jelínek (1 shared paper)Blake R. Wilde (1 shared paper)Mark S. Sharpley (1 shared paper)Daniel Braas (1 shared paper)Donald E. Ayer (1 shared paper)
- Journals
- Nature reviews. Cancer (1 paper)Cell (1 paper)Science (1 paper)Cancer Research (1 paper)Leukemia & lymphoma (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Andrew E. Whiteley
5 papers receiving 360 citations
Andrew E. Whiteley's Hit Papers
Peers
Comparison fields: 5 of 75
- Cancer Research 99
- Hematology 39
- Cell Biology 52
- Oncology 85
- Molecular Biology 197
Countries citing papers authored by Andrew E. Whiteley
This map shows the geographic impact of Andrew E. Whiteley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew E. Whiteley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew E. Whiteley more than expected).
Fields of papers citing papers by Andrew E. Whiteley
This network shows the impact of papers produced by Andrew E. Whiteley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew E. Whiteley. The network helps show where Andrew E. Whiteley may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew E. Whiteley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 194 | |
| 2 | 2021 | 129 | |
| 3 | Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis Hit paper breakdown → | 2024 | 38 |
| 4 | 2021 | 2 | |
| 5 | 2022 | 1 |
About Andrew E. Whiteley
Andrew E. Whiteley is a scholar working on Pulmonary and Respiratory Medicine, Hematology, Surgery, Molecular Biology and Genetics, having authored 5 papers that have together received 364 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (2 papers), Brain Metastases and Treatment (2 papers), Pancreatic function and diabetes (1 paper), Neuroblastoma Research and Treatments (1 paper), Nanoplatforms for cancer theranostics (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Cancer Research and Treatments (1 paper) and PI3K/AKT/mTOR signaling in cancer (1 paper). The work is most often cited by research in Cancer Research (99 citations), Hematology (39 citations), Cell Biology (52 citations), Oncology (85 citations) and Molecular Biology (197 citations). Andrew E. Whiteley has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Trevor Price, Dorothy A. Sipkins, Gaia Cantelli, David Jelínek, Blake R. Wilde, Mark S. Sharpley, Daniel Braas, Donald E. Ayer, David B. Shackelford and E. Schmid. Their work appears in journals such as Nature reviews. Cancer, Cell, Science, Cancer Research and Leukemia & lymphoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.